Table 6. Soluble CD40 ligand levels (sCD40L) in patients without and with the primary and secondary endpoints in the subgroup of patients with acute coronary syndrome (n = 125).

	No primary endpoint (n = 96)	Primary endpoint (n = 29)	p
sCD40L (ng/mL)	3.22 ± 0.3	2.36 ± 0.37	0.3
	No revascularization (n = 117)	Revascularization (n = 8)	p
sCD40L (ng/mL)	3.03 ± 0.26	2.86 ± 0.61	0.6
	No atherothrombotic event (n = 104)	Atherothrombotic event (n = 21)	p
sCD40L (ng/mL)	3.19 ± 0.28	2.17 ± 0.46	0.1

Continuous data are given as mean ± SEM.